Univest
Univest
  • Markets
  • Rama Phosphates Share Analyst Review: CMP, Performance, Target and 2026 Outlook

    • June 9, 2026
    • Posted by: Kunal Singla
    • Category: News
    No Comments
    Rama Phosphates Share Analyst Review

    Rama Phosphates share analyst review 2026: CMP Rs 120.04, 52-week range Rs 97.02-Rs 145.52, 12-month target Rs 150. Complete analyst review with sector outlook and risk assessment.

    read more
  • Oswal Agro Mills Share Analyst Review: CMP, Performance, Target and 2026 Outlook

    • June 9, 2026
    • Posted by: Neeraj Pandey
    • Category: News
    No Comments
    Oswal Agro Mills Share Analyst Review

    Oswal Agro Mills share analyst review 2026: CMP Rs 38.00, 52-week range Rs 22.00-Rs 62.00, 12-month target Rs 48. Complete analyst review with sector outlook and risk assessment.

    read more
  • MMP Industries Share Analyst Review: CMP, Performance, Target and 2026 Outlook

    • June 9, 2026
    • Posted by: Kunal Singla
    • Category: News
    No Comments
    MMP Industries Share Analyst Review

    MMP Industries share analyst review 2026: CMP Rs 385.00, 52-week range Rs 245.00-Rs 580.00, 12-month target Rs 481. Complete analyst review with sector outlook and risk assessment.

    read more
  • Puravankara Share Analyst Review: CMP, Performance, Target and 2026 Outlook

    • June 9, 2026
    • Posted by: Neeraj Pandey
    • Category: News
    No Comments
    Puravankara Share Analyst Review

    Puravankara share analyst review 2026: CMP Rs 207.00, 52-week range Rs 168.36-Rs 252.52, 12-month target Rs 259. Complete analyst review with sector outlook and risk assessment.

    read more
  • PNC Infratech Share Analyst Review: CMP, Performance, Target and 2026 Outlook

    • June 9, 2026
    • Posted by: Kunal Singla
    • Category: News
    No Comments
    PNC Infratech Share Analyst Review

    PNC Infratech share analyst review 2026: CMP Rs 205.00, 52-week range Rs 167.93-Rs 251.89, 12-month target Rs 256. Complete analyst review with sector outlook and risk assessment.

    read more
  • Oswal Greentech Share Analyst Review: CMP, Performance, Target and 2026 Outlook

    • June 9, 2026
    • Posted by: Neeraj Pandey
    • Category: News
    No Comments
    Oswal Greentech Share Analyst Review

    Oswal Greentech share analyst review 2026: CMP Rs 23.01, 52-week range Rs 18.80-Rs 28.18, 12-month target Rs 29. Complete analyst review with sector outlook and risk assessment.

    read more
  • Mold-Tek Packaging Share Analyst Review: CMP, Performance, Target and 2026 Outlook

    • June 9, 2026
    • Posted by: Kunal Singla
    • Category: News
    No Comments
    Mold-Tek Packaging Share Analyst Review

    Mold-Tek Packaging share analyst review 2026: CMP Rs 116.15, 52-week range Rs 94.44-Rs 141.64, 12-month target Rs 145. Complete analyst review with sector outlook and risk assessment.

    read more
  • New Delhi Television Share Analyst Review: CMP, Performance, Target and 2026 Outlook

    • June 9, 2026
    • Posted by: Neeraj Pandey
    • Category: News
    No Comments
    New Delhi Television Share Analyst Review

    New Delhi Television share analyst review 2026: CMP Rs 82.08, 52-week range Rs 67.80-Rs 101.68, 12-month target Rs 103. Complete analyst review with sector outlook and risk assessment.

    read more
  • Tarapur Transformers Share Analyst Review: CMP, Performance, Target and 2026 Outlook

    • June 9, 2026
    • Posted by: Neeraj Pandey
    • Category: News
    No Comments
    Tarapur Transformers Share Analyst Review

    Tarapur Transformers share analyst review 2026: CMP Rs 19.70, 52-week range Rs 18.81-Rs 20.79, 12-month target Rs 25. Complete analyst review with sector outlook and risk assessment.

    read more
  • MOIL Share Analyst Review: CMP, Performance, Target and 2026 Outlook

    • June 9, 2026
    • Posted by: Kunal Singla
    • Category: News
    No Comments
    MOIL Share Analyst Review

    MOIL share analyst review 2026: CMP Rs 293.00, 52-week range Rs 238.25-Rs 357.35, 12-month target Rs 366. Complete analyst review with sector outlook and risk assessment.

    read more
  • 1
  • …
  • 180
  • 181
  • 182
  • 183
  • 184
  • …
  • 768